A uremic toxin fraction (fraction 2-3-1) in the middle molecular mass range (300-2000 Da) containing a sodium potassium inhibitor pump was studied. As fraction 2-3-1 was known to be present in minute quantities in urine and plasma, erythrocyte lysates were used as an alternative source. Results show that fraction 2-3-1 is more abundant in erythrocytes than in normal urine. In addition, the fraction is present in a greater quantity in uremic erythrocytes than in normal blood cells. It is concluded that fraction 2-3-1 is concentrated at the erythrocyte level in uremic patients
ColeC.H., BalfeJ.M., WeltL.G.Induction of a ouabain sensitive ATPase defect by uremic plasma.Trans Assoc AM Phys1968; 81: 213–20.
3.
FervenzaF.C., HendryB.H., EllayJ.C.Effects of dialysis and transplantation on red cell Na pump function in renal failure.Nephron1989; 53: 121–8.
4.
KramerH.J., GospodinovD., KruckF.Functional and metabolic studies on red blood cell sodium transport in uremia.Nephron1976; 16: 344–58.
5.
BergströmJ., FürstP.Uremic toxins. In: DrukkerW., ParsonF.M., MaherJ.M., eds. Replacement of renal function by dialysis.Boston: Martinus Nijohff, 1983; 354–90.
MontiJ.P., GalliceP., CrevatA., EI MehdiM., DurandC., MurisascoA.Intra-erythrocytic sodium in uremic patients, as determined by high resolution 23Na nuclear magnetic resonance.Clin Chem1986; 32: 104–7.
